An Overview of the Recent Developments in Analytical Methodologies for Determination of Proton Pump Inhibitors in Bulk Drugs, Pharmaceuticals and Biological Matrices
 
More details
Hide details
1
Ramanbhaipatel College of Pharmacy, Charotar University of Science and Technology, Changa, Taluka: Petlad, District: Anand, Pin code: 388421 Gujarat, India
CORRESPONDING AUTHOR
Mehul M. Patel   

Ramanbhaipatel College of Pharmacy, Charotar University of Science and Technology, Changa, Taluka: Petlad, District: Anand, Pin code: 388421 Gujarat, India
Publish date: 2017-10-04
 
Eurasian J Anal Chem 2014;9(1):25–48
KEYWORDS
ABSTRACT
An extensive survey of the literature published in various analytical and pharmaceutical chemistry related journals has been conducted and the instrumental analytical methods which were developed and used for determination of proton pump inhibitorsin bulk drugs, formulations and biological fluids have been reviewed. This review covers the time period from 1990 to 2011 during which 80 analytical methods including all types of spectrophotmetric and chromatographic techniques were reported. HPLC with UV detection was found to be the technique of choice for many workers and more than 50 methods were based on LC and UV. A critical analysis of the reported data has been carried out and the present state-of-art of the analytical techniques for determination of omeprazole, esomeprazole, pantoprazole, rabeprazole, dexrabeprazole, tenatoprazole, lansoprazole and dexlansoprazole has been discussed.
 
REFERENCES (104)
1.
Majumdar D, Bebb J, Atherton J (2011) Helicobacter pylori infection and peptic ulcers, Gastroenterology Part 2 of 4. 39: 154-161.
 
2.
Gupta HP, Dhingra KSP, Pandey R (2008) Proton pump inhibitors at D.M.E, Portugaliae Electrochimica Acta. 26: 433-448.
 
3.
Alagarsamy V, Anti-ulcer agent, Text book of medicinal chemistry,6th edition. 2,121.
 
4.
Espinosa M, Sanchez A.J, Rojas F, Ojeda C (2007) Analytical methodologies for the determination of omeprazole: An overview, Journal of Pharmaceutical and Biomedical Analysis. 44 : 831-844.
 
5.
Rajic K, Novovic D, Marinkovic V, Agbaba D (2003) First-Order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities, Journal of Pharmaceutical and Biomedical Analysis. 32: 1019-1027.
 
6.
Sastry SP,Naidu , PY, Murty SSN (1997) Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations, Talanta. 44: 1211-1217.
 
7.
Kumaraswamy D , Stephen RB, Ch.Rajveer, Sudharshini S, Shrestha B , Rajasridhrar (2010) Statistical assurance of process validation by analytical method development and validation for omeprazole capsules and blend, Research Journal of Pharm. Biological and Chem. Sci. 1 50.
 
8.
Bhandage A, Bhosale A, Kasture A, Godse VP (2009) Extractive Spectrophotometric determination of omeprazole in pharmaceutical preparations, Tropical Journal of Pharmaceutical Research. 8: 449-454.
 
9.
Ahmed SS, Karajgi SR, Simpi CC, Sonawane S, Kalyane NV (2009) Visible spectrophotometric methods for the estimation of losartan potassium and omeprazole in single component pharmaceutical formulations, International Journal Of Pharmtech Research. 11247-1250.
 
10.
Shaghaghi M, Jouyban A (2008) Indirect spectrofluorimetric determination of omeprazole by its quenching effect on the fluorescence of Tb3+-1,10-phenanthroline complex in presence of bis (2-ethylhexyl) sulfosuccinate sodium in capsule formulations, Daru. 16: 256-263.
 
11.
Iuga C, Sorine MB (2009) Development of a validated RP-HPLC method for separation and determination of process-related impurities of omeprazole in bulk drugs, Farmacia. 57: 534-542.
 
12.
Schubert A, Werle AL, Schmidt CA (2003) Determination of omeprazole in bulk and injectable preparations by liquid chromatography, J. AOAC Int. 86: 501-4.
 
13.
Murakami FS,Cruz AP, Pereira RN, Valente BR, Silva MAS (2007) Development and validation of a RP-HPLC method to quantify omeprazole in delayed release tablets, J. Liq. Chromatogr. Relat. Technol. 30: 113-121.
 
14.
Vyas S, Patel A, Ladva KD, Joshi HS, Bapodra AH (2011) Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high-performance liquid chromatography, J. Pharmacy and bioallied sciences. 3: 310-314.
 
15.
Sluggett GW, Stong JD, Adams JH, Zhao Z (2001) Omeprazole determination using HPLC with coulometric detection, J. Pharm. Biomed. Anal. 25: 357–361.
 
16.
Yuen KH, Choy WP, Tan HY, Wong JW (2001) Improved high performance liquid chromatographic analysis of omeprazole in human plasma, J. Pharm. Biomed. Anal. 24: 715–719.
 
17.
Lagerstrgm P, Persson BA (1984) Determination of omeprazole and metabolites in plasma and urine by liquid chromatography, J.chromatogr. biomed. Appl. 309: 347-356.
 
18.
Kobayashi K, Chiba K, Tani M, Kuroiwa Y, Ishizaki T (1994) Development and preliminary application of a high performance liquid chromatographic assay for omeprazole metabolism in human liver microsomes, J. Pharm. Biomed. Anal. 12: 839-844.
 
19.
Vachhani R, Olds G, Velanovich V (2009) Esomeprazole: a proton pump inhibitor, Expert rev gastroenterol hepatol. 3: 15-27.
 
20.
http://www.rxlist.com/nexium-d... updated on 11/07/2010.
 
21.
http://www.rxlist.com//cgi/gen... accessed on 11/11/2008.
 
22.
http://dailymed.nlm.nih.gov/da... esomeprazole accessed on 11/11/2008.
 
23.
Mucklow JC (2002) Martindale: The Complete Drug Reference, 32nd Edition, Pharmaceutical Press, Great Britain 1225-1226.
 
24.
http://en.wikipedia.org/wiki/E.... accessed on 11/07/2010.
 
25.
Kumar PR, Shyale S, Gouda MM, Kumar SMS (2010) Physico-chemical characterization, UV spectrophotometric method development and validation studies of Esomeprazole Magnesium Trihydrate, J. Chem. Pharm. Res. 2: 484-490.
 
26.
Sharma MC, Sharma S (2011) Spectrophotometric methods for the estimation of esomeprazole magnesium trihydrate in pharmaceutical formulations using indigo carmine reagent, Intern. J. Pharmtech. Research, 3: 1186-1190.
 
27.
Gawande VV, Chandewar AV (2010) Spectroscopic estimation of esomeprazole magnesium in solid dosage form, International Journal Of Pharmacy&Technology. 2: 617-622.
 
28.
Patil SS, Kuchekar BS (2009) Development and statistical validation of spectrophotometric method for estimation of esomeprazole in tablet dosage form, Asian J. Research Chem. 2
 
29.
Rahman N, Bano Z, Azmi S (2008) Spectrophotometric determination of esomeprazole magnesium in commercial tablets using 5-sulfosalicylic acid and nbromosuccinimide, J. Chin.Chem.Soci. 55: 557-566.
 
30.
Reddy P, Reddy R, Reddy NR (2011) Simple Spectrophotometric determination of esomeprazole magnesium in pharmaceutical formulations, Asian J. Pharm. Hea. Sci. 1
 
31.
Rathi GG, Singh RK, Patel P, Singh R, Kumar B (2010) RP- HPLC method for the estimation of esomeprazole magnesium in bulk and its pharmaceutical dosage forms, International Journal Of Pharmaceutical Sciences And Research. 1
 
32.
Armagnac, A (2006) Development and validation of high performance liquid chromatographic method for the determination of esomeprazole in tablets, J. Food and Drug Anal. 14: 12-18.
 
33.
Zanitti L, Ferretti R, Gallinella B, Torre F, Sanna ML, Mosca A, Cirilli R (2010) Direct HPLC enantioseparation of omeprazole and its chiral impurities: Application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate, J. Pharm. Biomed. Anal. 52: 665–671.
 
34.
Sathiyaraj M, Amirtharaj V, Senthilkumar N (2010) Bioanalytical method development and validation of esomepraole in human plasma by LCMS/MS, Asian journal of research in chemistry. 3: 477.
 
35.
Hultman I, Stenhoff H, Liljeblad M (2007) Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry, J. Chromatogr. B. 848: 317–322.
 
36.
Gosavi SA, Bhavar GB, Chepurwar SB, Shirkhedkar AA, Bari SB, Surana SJ (2010) Estimation of esomeprazole in bulk and tablet dosage form by use of planar chromatography,Research Journal of Pharmacy and Technology, 3: 1185.
 
37.
Budavari S, Ed (1996) the Merck Index, 12th Edition, New Jersey 07065, USA, 1205
 
38.
Moustafa AM (2000) Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate, J. Pharm. Biomed. Anal. 22: 45–58.
 
39.
Suslu I, Altinoz S, Yildiz E (2003) Determination of pantoprazole in tablet dosage forms by two different spectrophotometric methods, J. Pharm. Sci. 28: 85-92.
 
40.
Basavaiah K, Vinay KB (2010) Sensitive and selective spectrophotometric determination of pantoprazole sodium in pharmaceuticals using permanganate, Chemical Industry & Chemical Engineering Quarterly, 16: 97-102.
 
41.
Reddy P, Reddy NK (2009) Development and validation of RP-HPLC for the pantoprazole sodium sesquihydrate in pharmaceutical dosage forms and human plasma, International Journal of ChemTech Research. 1: 195-198.
 
42.
Ramakrishna NVS, Vishwottam KN, Wishu S, Koteshwara M (2005) Highperformance liquid chromatography method for the quantification of pantoprazole in human plasma, J.Chromatogra. B. 822: 326–329.
 
43.
Balasekhara R, Chanduc BR, Bannotha CK, Khaggad M, Kanalae K, Shaikf RP (2010) Development and validation of a sensitive bioanalytical method for the quantitative estimation of Pantoprazole in human plasma samples by LC–MS/MS: Application to bioequivalence study, J. Chromatogra. B. 878: 1499–1505.
 
44.
Mohankandhasamy R, Dharuman J, Ponnilavarasan I, Thiagarajan M (2010) High - Performance Liquid Chromatography Method for the Quantification of Pantoprazole in Rat Plasma,International Journal of ChemTech Research. 2: 885-894.
 
45.
Bhaskara BL, Kumar UR, Basavaiah K (2011) Sensitive liquid chromatography–tandem mass spectrometry method for the determination of pantoprazole sodium in human urine, Arabian Journal of Chemistry. 4: 163-168.
 
46.
Patel SA (2011) High performance thin layer chromatographic method for estimation of pantoprazole in injection, International research journal of pharmacy. 2: 132-135.
 
47.
http://www.pharmainfo.net/revi... accessed on 12/02/2010.
 
48.
Desai CA, Samant BD (2002) Drug Review- Rabeprazole, Journal of Postgraduate Medicine.48: 80-81.
 
49.
http://www.rxlist.com/aciphex-... accessed on 11/11/2008.
 
50.
Gouda M, Shyale S, Putta R, Kumar SM (2010) Physico-chemical characterization, UV spectrophoto metric analytical method development and validation studies of Rabeprazole Sodium, J. Chem. Pharm. Res. 2: 187-192.
 
51.
Patel PM, Desai HJ, Patel RC, Patel NM (2007) Spectrophotometric method for estimation of rabeprazole, Indian Journal of Pharmaceutical Sciences. 69: 318-320.
 
52.
Osma A, Osman M (2009) Spectrofluorometry, thin layer chromatography, and column high-performance liquid chromatography determination of rabeprazole sodium in the presence of its acidic and oxidized degradation products, Journal of AOAC International. 92: 1373-1381.
 
53.
Madhuri D, Chandrasekhar KB, Ramakotaiah M, Somasekhar G, Harinadhababa K (2010) Validation of spectrophotometric determination of rabeprazole using Ferric Chloride (FeCl3), Int. J. Res. Pharm. Sci. 1: 209-211.
 
54.
Rahman N, Bano Z, Azmi SN (2008) Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry, Chem. Pharm. Bull. 56: 995-1001.
 
55.
Mandhanya M, Dubey N, Chaturvedi SC, Jain DK (2011) Simultaneously estimation of paracetamol, aceclofenac and rabeprazole in tablet dosage form using UV spectroscopy, Asian Journal of Pharmacy & Life Science.1
 
56.
Moustafa M (2003) Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products, J.Pharm. Biomed. Anal. 31: 229-242.
 
57.
Rao AL, Kumar BNV, Sankar GG (2008) Development of RP-HPLC method for the estimation of rabeprazole in pure and tablet dosage form, E-Journal of Chemistry. 5: 1149-1153.
 
58.
Rao RN, Raju A, Nagaraju D(2006) Enantiospecific resolution of rabeprazole by liquid chromatography on amylose-derived chiral stationary phase using photo diode array and polarimetric detectors in series, Talanta. 70: 805–810.
 
59.
Elumalai S, Aher K, Bhavar G, Gupta S (2011) Development and validation of RPHPLC method for determination of content uniformity of rabeprazole sodium in its tablets dosage form, Journal of Applied Pharmaceutical Science. 1: 165-170.
 
60.
Singh SS, Jain M, Shah H, Gupta S, Thakker P (2004) Direct injection, column switching–liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study, J. Chromatogra. B. 813: 247–254.
 
61.
Ramakrishna NVS, Vishwottam KN, Wishu S, Koteshwara M, Kumar SS (2005) High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction, J. Chromatogra. B. 816: 209–214.
 
62.
Shimizu M, Sugawara K, Tateishi T (2005) Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high performance liquid chromatography and its application to pharmacokinetic study, J. Chromatogra. B, 824: 238–243.
 
63.
Tada H , Satoh S , Habuchi T , Suzuki T (2006) Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction, J. Pharm. Biomed. Anal. 41: 565–570.
 
64.
Zhang Y, Zhong D (2004) Quantification of rabeprazole in human plasma by liquid chromatography–tandem mass spectrometry, Analytica Chimica Acta. 523: 171–175.
 
65.
Reddy P, Reddy MS (2009) Development and validation of RP-HPLC for the rabeprazole sodium in pharmaceutical formulations and human plasma, Asian J. Research Chem. 2
 
66.
Hishinum T, Kaori S, Yamaguchi H (2008) Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry, J.Chromatogra. B. 870: 38–45.
 
67.
Bharekar V, Mulla T, Rajput M, Yadav SS, Rao JR (2011) Validated HPTLC method for simultaneous estimation of Rabeprazole Sodium, Paraetamol and Aceclofenac in bulk drug and formulation, Der Pharma Chemica. 3: 171-179.
 
68.
Shirkhedkar AA, Surana SJ (2009) Application of stability-indicating RP-TLC densitometric determination of rabeprazole sodium in bulk and pharmaceutical formulation, Eurasian J. Anal. Chem. 4: 87-97.
 
69.
Jain S (2009) A postmarketing surveillance study of dexrabeprazole in the treatment of acid peptic disorders, J. Indian Med. Assoc, 107(2), 111
 
70.
Sahajwalla CJ (2004) New Drug Development:Regulatory paradigms for clinical Pharmacology and Biopharmaceutics, 141, Marcel Dekker Inc., New York, 141, 421
 
71.
Shedpure PS, Dole MN, Sawant SD, Patel PA (2011) Spectrophotometric determination of dexrabeprazole sodium in bulk &tablet dosage form by first order derivative spectroscopy and area under the curve, International Journal of Pharmacy & Technology. 3: 2565-2573.
 
72.
Patil KR, Rane VP, Yeole RD, Sangshetti JN, Shinde DB (2011) Validated chiral LC method for dexrabeprazole on reverse phase amylose based stationary phase, Journal of the Chilean Chemical Society. 2: 706-708.
 
73.
Robinson M (2005) Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases, Int. J. Clin. Pract. 59: 709.
 
74.
Sugumaran M, Rao RN, Jothieswari D (2010) UV- Spectrophotometric determination of tenatoprazole from its bulk and tablets, International journal of pharma and bio sciences. 1
 
75.
Kumaraswamy G, Rajendrakumar JM, Sheshagirirao JVLN, Kumar U, Arunadevi M (2011) Spectrophotometric determination of tenatoprazole in bulk drug and pharmaceutical dosage form, Research Journal of Pharmacy and Technology. 4: 574.
 
76.
Mahadika M, Bhusaria V, Kulkarnib M, Dhaneshwara S (2009) LC–UV and LC–MS evaluation of stress degradation behaviour of tenatoprazole, Journal of Pharmaceutical and Biomedical Analysis. 50: 787–793.
 
77.
Sugumaran M, Poornima M, Kumar MY, Ramarajasekhar S (2011) RP-HPLC method for the determination of Tenatoprazole in pharmaceutical formulations, Der Pharmacia Sinica. 2: 12-16.
 
78.
Kumar JMR, Rao JVLNS (2011) Development and validation of RP – HPLC method for the estimation of tenatoprazole in bulk and tablet dosage form, International Journal of ChemTech Research. 3: 495-501.
 
79.
Liu P, Sun B, Lu X, Qin F, Li F (2007) HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule, Biomedical Chromatography. 21: 89–93.
 
80.
Dhaneshwar SR, Bhusari VK, Mahadik MV, Santakumari B (2008) Application of a stability-indicating thin-layer chromatographic method to the determination of tenatoprazole in pharmaceutical dosage forms, J. AOAC Int. 92: 387-93.
 
81.
Brummer RJ, Geerling BJ, Stockbrugger RW (1997) Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration, Dig Dis Sci.42: 2132–2137.
 
82.
Threlkeld DS (1998) Gastrointestinal Drugs, Proton Pump Inhibitors. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons 305
 
83.
Tolman KG, Sanders SW, Buchi KN (1997) The effects of oral doses of lansoprazole and omeprazole on gastric pH, J Clin Gastroenterol. 24: 65-70.
 
84.
Fitton A, Wiseman L (1996) Pantoprazole: A Review of its Pharmacological Properties and Therapeutic Use in Acid-Related Disorders, Drugs. 51: 460-482.
 
85.
Matheson AJ, Jarvis B (2001) Lansoprazole: an update of its place in the management of acid-related disorders, Drugs. 61: 1801-1833.
 
86.
Bown RL (2002) An overview of the pharmacology, efficacy, safety and costeffectiveness of lansoprazole, Int. J. Clin. Pract. 56: 132-139.
 
87.
Basavaiah K, Ramakrishna V, Anilkumar UR (2006) Sensitive spectrophotometric determination of lansoprazole in pharmaceuticals using ceric ammonium sulphate based on redox and complex formation reactions, Ecletica Quimica. 31
 
88.
Sudheer M, Satish AV, Nagarjuna S (2011) New UV-spectrophotometric method for the determination of lansoprazole in pharmaceutical dosage form and its application to protein binding study, Journal of Pharmacy Research. 4: 1586-1587.
 
89.
Nuran Z (1999) Determination of Lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods, Journal of Pharmaceutical and Biomedical Analysis. 20: 599–606.
 
90.
Yeniceli D, Dogrukol D, Tuncel M (2004) Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection, J Pharm Biomed Anal. 36: 145-8.
 
91.
Basavaiah K , Vinay K (2011) Quantitative determination of lansoprozole in capsules and spiked human urine by spectrophotometry through ion-pair complex formation reaction, Journal of Saudi Chemical Society.
 
92.
Reddy BPK, Reddy YR, Ramachandran D (2009) Determination of pantoprazole sodium and lansoprazole in individual tablet dosage forms by RP-HPLC using single mobile phase, E-Journal of Chemistry. 6: 489-494.
 
93.
Kumar S, Kumar D, Rajkumar T, Kumar EU, Geetha AS, Diwedi D (2010) Development and validation of RP-HPLC method for the estimation of Lansoprazole in tablet dosage form, J. Chem. Pharm. Res. 2: 291-295.
 
94.
Katsuki H, Yagi H, Arimori K (1996) Determination of R(+) and S(-) lansoprazole using chiral stationary phase liquid chromatography and their enantioselactive pharmacokinetics in humans, Pharmaceutical research, 13: 611-615.
 
95.
Brown SD, Connor JD, Smallwood NC, Lugo RA (2011) Quantification of lansoprazole in oral suspension by ultra-high-performance liquid chromatography hybrid ion-trap time-of-flightmass spectrometry, International Journal of Analytical Chemistry. 6
 
96.
Momani A, Rababah MH (2010) Validation of HPLC and FIA spectrophotometric methods for the determination of lansoprazole in pharmaceutical dosage forms and human plasma, American Journal of Analytical Chemistry. 1: 34-39.
 
97.
Oliveira CH, Astigarraga REB, Abib E, Mendes GD (2003) Lansoprazole quantification in human plasma by liquid chromatography–electrospray tandem mass spectrometry, Journal of Chromatography B. 783: 453–459.
 
98.
Miura M, Tada H, Suzuki T (2004) Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solidphase extraction, Journal of Chromatography B. 804: 389–395.
 
99.
Pandya KK , Mody VD , Satia MC, Modi IA , Modi RI , Chakravarthy BK , Gandhi TP (1997) High-performance thin-layer chromatographic method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic studies,Journal of Chromatography B. 693: 199–204.
 
100.
Aoki S , Okumura M , Yashiki T, High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine, Journal of Chromatography and Biomedical Applications. 57, 283-290.
 
101.
Katsuki H, Hamada A, Nakamura C, Arimori K (2001) High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes, Journal of Chromatography B. 757: 127–133.
 
102.
Sherif ZA, Mohamed A, Bardeicy MG (2005) Stability‐indicating methods for the determination of lansoprazole, Spectroscopy Letters, 38: 77-93.
 
103.
 
104.
Bharathi DV, Jagadeesh B, Ravindranath LK, Veera KNJ, Venkateswarulu V - (2011) Development and validation of a highly sensitive LC-MS/MS method for quantitation of dexlansoprazole in human plasma: application to a human pharmacokinetic study,Biomedical Chromatography.
 
eISSN:1306-3057